---
id: chlamydia-trachomatis_324
category: organisms
tags: [chlamydia-trachomatis, LGV, lymphogranuloma-venereum, trachoma, STI, serovars, doxycycline]
deck: Infectious Diseases
created: 2025-01-11
modified: 2025-01-11
---

## Chlamydia trachomatis

**Q:** What are the disease syndromes caused by different C. trachomatis serovars and their treatments?

**A:**

**Overview:**
- **Obligate intracellular bacterium**
- **15 serovars** (A-K, L1-L3) causing distinct clinical syndromes

**Serovars and Associated Diseases:**

| Serovars | Disease | Clinical Features | Treatment |
|----------|---------|-------------------|-----------|
| **A, B, Ba, C** | **Trachoma** | Leading infectious cause of blindness worldwide; chronic conjunctivitis → scarring → trichiasis → corneal opacity | **Azithromycin 1 g PO single dose** OR tetracycline eye ointment BID × 6 weeks; **SAFE strategy** (Surgery, Antibiotics, Facial cleanliness, Environmental improvement) |
| **D-K** | **Urogenital infections** (most common STI) | **Men**: Urethritis, epididymitis; **Women**: Cervicitis, PID, infertility; **Neonates**: Inclusion conjunctivitis, pneumonia | **Azithromycin 1 g PO single dose** OR **doxycycline 100 mg PO BID × 7 days** |
| **L1, L2, L3** | **Lymphogranuloma venereum (LGV)** | **Stage 1**: Painless genital ulcer/papule; **Stage 2**: **Painful inguinal lymphadenopathy** ("buboes"), groove sign; **Stage 3**: Proctocolitis (MSM), genital elephantiasis, rectal strictures | **Doxycycline 100 mg PO BID × 21 days** (preferred) OR **azithromycin 1 g PO weekly × 3 weeks** |

**LGV Key Features:**

**Serovars L1-L3:**
- **Invasive** (unlike D-K serovars which cause superficial infection)
- More severe inflammation

**Clinical Stages:**
- **Primary**: Transient painless genital ulcer (often missed)
- **Secondary**: **Inguinal syndrome** (painful buboes, "groove sign" = femoral + inguinal nodes separated by inguinal ligament)
- **Tertiary**: Chronic complications (proctocolitis in MSM, genital elephantiasis, strictures)

**Modern Epidemiology:**
- **MSM population**: LGV proctitis/proctocolitis (anorectal LGV)
- Often co-infected with HIV

**Treatment Duration Rationale:**
- **LGV requires 21 days** (invasive infection) vs **7 days for uncomplicated urogenital** chlamydia

**Neonatal Chlamydia:**
- **Inclusion conjunctivitis** (5-12 days post-delivery): purulent discharge
- **Pneumonia** (1-3 months): afebrile, staccato cough, hyperinflation, eosinophilia
- Treatment: **Azithromycin suspension** (NOT topical therapy alone)

**Key Points:**
- **Serovars D-K**: Most common STI (urogenital); treat × 7 days
- **Serovars L1-L3**: LGV (invasive, buboes); treat × **21 days**
- **Serovars A-C**: Trachoma (blindness); single-dose azithromycin

**Mnemonic - "DK = D-K serovars, Don't Know you have it (often asymptomatic); L = Long treatment (21 days), Lymph nodes (buboes)"**

**Pearl:** LGV (L1-L3) requires **21-day doxycycline** course (invasive infection with buboes) vs 7 days for uncomplicated urogenital chlamydia (D-K serovars). "Groove sign" (inguinal + femoral adenopathy separated by ligament) is classic for LGV.

**Media:**

**Sources:** [CDC STI Guidelines LGV 2024], [StatPearls LGV NBK537362], [Clin Infect Dis Azithromycin LGV 2021], [Merck Manual LGV]
